Share Price and Basic Stock Data
Last Updated: May 31, 2025, 8:14 pm
| PEG Ratio | -2.34 |
|---|
Competitors of Archean Chemical Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 5,758 Cr. | 888 | 919/534 | 4,799 | 52.9 | 0.00 % | 1.07 % | 0.57 % | 10.0 |
| Emmessar Biotech & Nutrition Ltd | 17.2 Cr. | 34.5 | 64.0/27.2 | 53.9 | 15.4 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 236 Cr. | 301 | 415/238 | 10.0 | 211 | 2.66 % | 23.0 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 7,727 Cr. | 626 | 832/408 | 36.0 | 152 | 0.48 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 316 Cr. | 404 | 580/341 | 15.6 | 132 | 0.74 % | 24.2 % | 21.4 % | 10.0 |
| Industry Average | 5,874.75 Cr | 563.74 | 523.43 | 156.59 | 0.46% | 13.48% | 10.18% | 7.82 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 373 | 400 | 293 | 365 | 382 | 343 | 290 | 413 | 283 | 211 | 238 | 243 | 322 |
| Expenses | 212 | 239 | 175 | 205 | 188 | 208 | 195 | 267 | 195 | 139 | 162 | 158 | 232 |
| Operating Profit | 160 | 161 | 119 | 160 | 194 | 135 | 96 | 146 | 88 | 73 | 76 | 84 | 90 |
| OPM % | 43% | 40% | 40% | 44% | 51% | 39% | 33% | 35% | 31% | 34% | 32% | 35% | 28% |
| Other Income | 4 | 9 | 19 | 8 | 9 | 11 | 12 | 10 | 14 | 12 | -26 | 12 | 12 |
| Interest | 39 | 39 | 35 | 19 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Depreciation | 17 | 18 | 17 | 17 | 17 | 17 | 17 | 18 | 17 | 18 | 18 | 19 | 19 |
| Profit before tax | 107 | 113 | 86 | 131 | 182 | 125 | 88 | 136 | 82 | 65 | 30 | 75 | 80 |
| Tax % | 24% | 25% | 26% | 25% | 25% | 25% | 24% | 25% | 28% | 26% | 26% | 25% | 27% |
| Net Profit | 82 | 85 | 64 | 98 | 137 | 94 | 66 | 102 | 60 | 48 | 22 | 56 | 58 |
| EPS in Rs | 8.50 | 8.79 | 6.63 | 7.99 | 11.12 | 7.65 | 5.39 | 8.28 | 4.83 | 3.93 | 1.77 | 4.56 | 4.72 |
Last Updated: May 31, 2025, 6:58 am
Below is a detailed analysis of the quarterly data for Archean Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 243.00 Cr. (Dec 2024) to 322.00 Cr., marking an increase of 79.00 Cr..
- For Expenses, as of Mar 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 158.00 Cr. (Dec 2024) to 232.00 Cr., marking an increase of 74.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Dec 2024) to 90.00 Cr., marking an increase of 6.00 Cr..
- For OPM %, as of Mar 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 35.00% (Dec 2024) to 28.00%, marking a decrease of 7.00%.
- For Other Income, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 12.00 Cr..
- For Interest, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Dec 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 19.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Dec 2024) to 80.00 Cr., marking an increase of 5.00 Cr..
- For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Dec 2024) to 27.00%, marking an increase of 2.00%.
- For Net Profit, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Dec 2024) to 58.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 4.72. The value appears strong and on an upward trend. It has increased from 4.56 (Dec 2024) to 4.72, marking an increase of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 4:27 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 439 | 566 | 608 | 741 | 1,130 | 1,441 | 1,330 | 1,014 |
| Expenses | 356 | 497 | 460 | 478 | 663 | 807 | 865 | 691 |
| Operating Profit | 83 | 69 | 148 | 262 | 467 | 634 | 464 | 322 |
| OPM % | 19% | 12% | 24% | 35% | 41% | 44% | 35% | 32% |
| Other Income | 6 | 121 | 8 | 14 | 13 | 44 | 47 | 9 |
| Interest | 102 | 114 | 122 | 130 | 162 | 97 | 10 | 9 |
| Depreciation | 73 | 47 | 52 | 55 | 67 | 69 | 70 | 73 |
| Profit before tax | -85 | 29 | -17 | 90 | 251 | 513 | 431 | 250 |
| Tax % | -7% | -41% | 105% | 26% | 25% | 25% | 25% | 26% |
| Net Profit | -79 | 41 | -36 | 67 | 189 | 384 | 322 | 185 |
| EPS in Rs | -79.16 | 21.31 | -18.50 | 34.56 | 19.58 | 31.18 | 26.12 | 14.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 8% | 11% | 20% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 151.90% | -187.80% | 286.11% | 182.09% | 103.17% | -16.15% | -42.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -339.70% | 473.92% | -104.02% | -78.91% | -119.32% | -26.40% |
Archean Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | -4% |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 52% |
| 3 Years: | 5% |
| TTM: | -33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 22% |
| Last Year: | 12% |
Last Updated: Unknown
Balance Sheet
Last Updated: May 13, 2025, 2:15 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 19 | 19 | 19 | 19 | 25 | 25 | 25 |
| Reserves | -38 | 24 | -12 | 55 | 243 | 1,408 | 1,682 | 1,855 |
| Borrowings | 968 | 754 | 854 | 904 | 897 | 69 | 39 | 108 |
| Other Liabilities | 316 | 439 | 568 | 457 | 372 | 254 | 246 | 261 |
| Total Liabilities | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 |
| Fixed Assets | 940 | 914 | 882 | 1,042 | 1,086 | 1,097 | 1,086 | 1,071 |
| CWIP | 0 | 9 | 193 | 19 | 17 | 33 | 21 | 28 |
| Investments | 0 | 0 | 47 | 41 | 16 | 215 | 347 | 202 |
| Other Assets | 316 | 314 | 308 | 332 | 412 | 410 | 537 | 947 |
| Total Assets | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 |
Below is a detailed analysis of the balance sheet data for Archean Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,682.00 Cr. (Mar 2024) to 1,855.00 Cr., marking an increase of 173.00 Cr..
- For Borrowings, as of Mar 2025, the value is 108.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 39.00 Cr. (Mar 2024) to 108.00 Cr., marking an increase of 69.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 261.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 246.00 Cr. (Mar 2024) to 261.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,249.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,991.00 Cr. (Mar 2024) to 2,249.00 Cr., marking an increase of 258.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,086.00 Cr. (Mar 2024) to 1,071.00 Cr., marking a decrease of 15.00 Cr..
- For CWIP, as of Mar 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Mar 2025, the value is 202.00 Cr.. The value appears to be declining and may need further review. It has decreased from 347.00 Cr. (Mar 2024) to 202.00 Cr., marking a decrease of 145.00 Cr..
- For Other Assets, as of Mar 2025, the value is 947.00 Cr.. The value appears strong and on an upward trend. It has increased from 537.00 Cr. (Mar 2024) to 947.00 Cr., marking an increase of 410.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,249.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,991.00 Cr. (Mar 2024) to 2,249.00 Cr., marking an increase of 258.00 Cr..
Notably, the Reserves (1,855.00 Cr.) exceed the Borrowings (108.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -885.00 | -685.00 | -706.00 | -642.00 | -430.00 | 565.00 | 425.00 | 214.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 43 | 27 | 34 | 49 | 30 | 43 |
| Inventory Days | 830 | 238 | 999 | 532 | |||
| Days Payable | 1,035 | 398 | 1,689 | 415 | |||
| Cash Conversion Cycle | -183 | -116 | -663 | 34 | 49 | 30 | 160 |
| Working Capital Days | -70 | 9 | -34 | 31 | 52 | 50 | 56 |
| ROCE % | 3% | 13% | 24% | 39% | 46% | 26% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 4,400,000 | 1.12 | 278.74 | 4,400,000 | 2025-04-22 14:12:24 | 0% |
| SBI Multicap Fund | 4,094,476 | 1.77 | 259.39 | 4,094,476 | 2025-04-22 15:56:51 | 0% |
| DSP Small Cap Fund | 2,297,376 | 1.05 | 145.54 | 2,297,376 | 2025-04-22 15:56:51 | 0% |
| Nippon India Small Cap Fund | 1,373,373 | 0.19 | 87 | 1,373,373 | 2025-04-22 15:56:51 | 0% |
| HDFC Multi Cap Fund | 1,095,175 | 0.59 | 69.38 | 1,095,175 | 2025-04-22 15:56:51 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 700,000 | 2.76 | 44.35 | 700,000 | 2025-04-22 15:56:51 | 0% |
| Kotak Small Cap Fund - Regular Plan | 636,952 | 0.28 | 40.35 | 636,952 | 2025-04-22 15:56:51 | 0% |
| Quant Small Cap Fund | 496,073 | 0.2 | 31.43 | 496,073 | 2025-04-22 15:56:51 | 0% |
| ITI Multi Cap Fund | 159,111 | 1.2 | 10.08 | 159,111 | 2025-04-22 15:56:51 | 0% |
| Motilal Oswal Multi Asset Fund | 50,000 | 3.09 | 3.17 | 50,000 | 2025-04-22 15:56:51 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 25.90 | 34.66 | 18.22 |
| Diluted EPS (Rs.) | 25.87 | 34.59 | 18.22 |
| Cash EPS (Rs.) | 31.55 | 36.67 | 26.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.89 | 116.29 | 26.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.89 | 116.29 | 26.75 |
| Revenue From Operations / Share (Rs.) | 107.79 | 117.11 | 117.35 |
| PBDIT / Share (Rs.) | 41.00 | 55.04 | 49.78 |
| PBIT / Share (Rs.) | 35.30 | 49.46 | 42.84 |
| PBT / Share (Rs.) | 34.62 | 41.58 | 26.06 |
| Net Profit / Share (Rs.) | 25.85 | 31.09 | 19.54 |
| NP After MI And SOA / Share (Rs.) | 25.85 | 31.09 | 19.54 |
| PBDIT Margin (%) | 38.04 | 46.99 | 42.42 |
| PBIT Margin (%) | 32.75 | 42.23 | 36.50 |
| PBT Margin (%) | 32.11 | 35.50 | 22.20 |
| Net Profit Margin (%) | 23.98 | 26.54 | 16.64 |
| NP After MI And SOA Margin (%) | 23.98 | 26.54 | 16.64 |
| Return on Networth / Equity (%) | 18.74 | 26.73 | 73.02 |
| Return on Capital Employeed (%) | 22.67 | 38.44 | 30.43 |
| Return On Assets (%) | 15.51 | 21.79 | 12.29 |
| Long Term Debt / Equity (X) | 0.03 | 0.00 | 3.27 |
| Total Debt / Equity (X) | 0.03 | 0.01 | 3.28 |
| Asset Turnover Ratio (%) | 0.69 | 0.87 | 0.00 |
| Current Ratio (X) | 5.38 | 3.35 | 2.27 |
| Quick Ratio (X) | 4.44 | 2.37 | 1.58 |
| Inventory Turnover Ratio (X) | 0.32 | 0.31 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.37 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.23 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 82.63 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 85.77 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 59.80 | 6.99 | 2.97 |
| Interest Coverage Ratio (Post Tax) (X) | 38.70 | 4.95 | 2.16 |
| Enterprise Value (Cr.) | 8283.52 | 7995.88 | 0.00 |
| EV / Net Operating Revenue (X) | 6.23 | 5.55 | 0.00 |
| EV / EBITDA (X) | 16.37 | 11.81 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 6.22 | 5.56 | 0.00 |
| Retention Ratios (%) | 82.62 | 0.00 | 0.00 |
| Price / BV (X) | 4.86 | 5.60 | 0.00 |
| Price / Net Operating Revenue (X) | 6.22 | 5.56 | 0.00 |
| EarningsYield | 0.03 | 0.04 | 0.00 |
After reviewing the key financial ratios for Archean Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 25.90. This value is within the healthy range. It has decreased from 34.66 (Mar 23) to 25.90, marking a decrease of 8.76.
- For Diluted EPS (Rs.), as of Mar 24, the value is 25.87. This value is within the healthy range. It has decreased from 34.59 (Mar 23) to 25.87, marking a decrease of 8.72.
- For Cash EPS (Rs.), as of Mar 24, the value is 31.55. This value is within the healthy range. It has decreased from 36.67 (Mar 23) to 31.55, marking a decrease of 5.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 137.89. It has increased from 116.29 (Mar 23) to 137.89, marking an increase of 21.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 137.89. It has increased from 116.29 (Mar 23) to 137.89, marking an increase of 21.60.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 107.79. It has decreased from 117.11 (Mar 23) to 107.79, marking a decrease of 9.32.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 41.00. This value is within the healthy range. It has decreased from 55.04 (Mar 23) to 41.00, marking a decrease of 14.04.
- For PBIT / Share (Rs.), as of Mar 24, the value is 35.30. This value is within the healthy range. It has decreased from 49.46 (Mar 23) to 35.30, marking a decrease of 14.16.
- For PBT / Share (Rs.), as of Mar 24, the value is 34.62. This value is within the healthy range. It has decreased from 41.58 (Mar 23) to 34.62, marking a decrease of 6.96.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 25.85. This value is within the healthy range. It has decreased from 31.09 (Mar 23) to 25.85, marking a decrease of 5.24.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 25.85. This value is within the healthy range. It has decreased from 31.09 (Mar 23) to 25.85, marking a decrease of 5.24.
- For PBDIT Margin (%), as of Mar 24, the value is 38.04. This value is within the healthy range. It has decreased from 46.99 (Mar 23) to 38.04, marking a decrease of 8.95.
- For PBIT Margin (%), as of Mar 24, the value is 32.75. This value exceeds the healthy maximum of 20. It has decreased from 42.23 (Mar 23) to 32.75, marking a decrease of 9.48.
- For PBT Margin (%), as of Mar 24, the value is 32.11. This value is within the healthy range. It has decreased from 35.50 (Mar 23) to 32.11, marking a decrease of 3.39.
- For Net Profit Margin (%), as of Mar 24, the value is 23.98. This value exceeds the healthy maximum of 10. It has decreased from 26.54 (Mar 23) to 23.98, marking a decrease of 2.56.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.98. This value exceeds the healthy maximum of 20. It has decreased from 26.54 (Mar 23) to 23.98, marking a decrease of 2.56.
- For Return on Networth / Equity (%), as of Mar 24, the value is 18.74. This value is within the healthy range. It has decreased from 26.73 (Mar 23) to 18.74, marking a decrease of 7.99.
- For Return on Capital Employeed (%), as of Mar 24, the value is 22.67. This value is within the healthy range. It has decreased from 38.44 (Mar 23) to 22.67, marking a decrease of 15.77.
- For Return On Assets (%), as of Mar 24, the value is 15.51. This value is within the healthy range. It has decreased from 21.79 (Mar 23) to 15.51, marking a decrease of 6.28.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.03, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.03. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.03, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.69. It has decreased from 0.87 (Mar 23) to 0.69, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 24, the value is 5.38. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 23) to 5.38, marking an increase of 2.03.
- For Quick Ratio (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 2. It has increased from 2.37 (Mar 23) to 4.44, marking an increase of 2.07.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.32. This value is below the healthy minimum of 4. It has increased from 0.31 (Mar 23) to 0.32, marking an increase of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 17.37. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 17.37, marking an increase of 17.37.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 14.23. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 14.23, marking an increase of 14.23.
- For Earning Retention Ratio (%), as of Mar 24, the value is 82.63. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 82.63, marking an increase of 82.63.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 85.77. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 85.77, marking an increase of 85.77.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 59.80. This value is within the healthy range. It has increased from 6.99 (Mar 23) to 59.80, marking an increase of 52.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 38.70. This value is within the healthy range. It has increased from 4.95 (Mar 23) to 38.70, marking an increase of 33.75.
- For Enterprise Value (Cr.), as of Mar 24, the value is 8,283.52. It has increased from 7,995.88 (Mar 23) to 8,283.52, marking an increase of 287.64.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.23. This value exceeds the healthy maximum of 3. It has increased from 5.55 (Mar 23) to 6.23, marking an increase of 0.68.
- For EV / EBITDA (X), as of Mar 24, the value is 16.37. This value exceeds the healthy maximum of 15. It has increased from 11.81 (Mar 23) to 16.37, marking an increase of 4.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.22. This value exceeds the healthy maximum of 3. It has increased from 5.56 (Mar 23) to 6.22, marking an increase of 0.66.
- For Retention Ratios (%), as of Mar 24, the value is 82.62. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 82.62, marking an increase of 82.62.
- For Price / BV (X), as of Mar 24, the value is 4.86. This value exceeds the healthy maximum of 3. It has decreased from 5.60 (Mar 23) to 4.86, marking a decrease of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.22. This value exceeds the healthy maximum of 3. It has increased from 5.56 (Mar 23) to 6.22, marking an increase of 0.66.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Archean Chemical Industries Ltd:
- Net Profit Margin: 23.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.67% (Industry Average ROCE: 13.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.74% (Industry Average ROE: 10.18%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 38.7
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36 (Industry average Stock P/E: 523.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.98%
About the Company - Qualitative Analysis
Archean Chemical Industries Ltd. is a Private Limited Listed company incorporated on 14/07/2009 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24298TN2009PLC072270 and registration number is 072270. Currently Company is involved in the business activities of Salt production by evaporation of sea water or other saline waters. Company's Total Operating Revenue is Rs. 1013.79 Cr. and Equity Capital is Rs. 24.69 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | No. 2, North Crescent Road, Chennai (Madras) Tamil Nadu 600017 | info@archeanchemicals.com http://www.archeanchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ranjit Pendurthi | Managing Director |
| Mr. Ravi Pendurthi | Non Independent Director |
| Mr. Subrahmanyam Meenakshisundaram | Non Independent Director |
| Ms. Padma Chandrasekaran | Independent Director |
| Mr. Chittoor Ghatambu Sethuram | Independent Director |
| Mr. Kandheri Munaswami Mohandass | Independent Director |
FAQ
What is the intrinsic value of Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd's intrinsic value (as of 31 May 2025) is ₹527.83 — 15.68% lower the current market price of 626.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,727 Cr. market cap, FY2025-2026 high/low of ₹832/408, reserves of 1,855 Cr, and liabilities of 2,249 Cr.
What is the Market Cap of Archean Chemical Industries Ltd?
The Market Cap of Archean Chemical Industries Ltd is 7,727 Cr..
What is the current Stock Price of Archean Chemical Industries Ltd as on 31 May 2025?
The current stock price of Archean Chemical Industries Ltd as on 31 May 2025 is 626.
What is the High / Low of Archean Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Archean Chemical Industries Ltd stocks is ₹832/408.
What is the Stock P/E of Archean Chemical Industries Ltd?
The Stock P/E of Archean Chemical Industries Ltd is 36.0.
What is the Book Value of Archean Chemical Industries Ltd?
The Book Value of Archean Chemical Industries Ltd is 152.
What is the Dividend Yield of Archean Chemical Industries Ltd?
The Dividend Yield of Archean Chemical Industries Ltd is 0.48 %.
What is the ROCE of Archean Chemical Industries Ltd?
The ROCE of Archean Chemical Industries Ltd is 16.0 %.
What is the ROE of Archean Chemical Industries Ltd?
The ROE of Archean Chemical Industries Ltd is 12.0 %.
What is the Face Value of Archean Chemical Industries Ltd?
The Face Value of Archean Chemical Industries Ltd is 2.00.